estrenes - CISMeF

Preferred Label : estrenes;

MeSH definition : Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.;

MeSH synonym : 19 norandrostenes; 19-norandrostenes;

MeSH annotation : do not confuse with ESTRANES;

Wikipedia link : https://en.wikipedia.org/wiki/Estrenes;

Is substance : O;

Details

Origin ID

D004963;

UMLS CUI

C0014925;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Ne pas confondre avec
- estranes [MeSH Descriptor]
Record concept(s)
- estrenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (4R)-5,10-secoestra-4,5-diene-3,10,17-trione [MeSH Supplementary Concept]
- (6-(2-aminoethylamino)hexyl)carbamic acid 2-(6-(7-estra-1,3,5,(10)-triene)hexylamino)ethyl ester platinum(II) dichloride [MeSH Supplementary Concept]
- 1,3,5(10)-estratriene [MeSH Supplementary Concept]
- 1,3,5,(10),16-estratetraen-3-ol [MeSH Supplementary Concept]
- 1,5(10)-estradiene-3,4,17-trione [MeSH Supplementary Concept]
- 1,6-dithiabenz(3,4)estra-3,5(10),8,14-tetraen-17-one [MeSH Supplementary Concept]
- 1,6-dithiabenz(3,4)homoestra-3,5(10),8,14-tetraen-17-one [MeSH Supplementary Concept]
- 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione [MeSH Supplementary Concept]
- 1-hydroxy-1,3,5(10)-estratriene [MeSH Supplementary Concept]
- 10 beta-hydroxy-4-estrene-3,17-dione formate [MeSH Supplementary Concept]
- 10-(1-azirinyl)estr-4-en-3,17-dione [MeSH Supplementary Concept]
- 10-(2-aminoethyl)estr-5-ene-3,17-dione, cyclic bis(1,2-ethanediylacetal) [MeSH Supplementary Concept]
- 10-amino-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-chloroestradien-3-one [MeSH Supplementary Concept]
- 10-hydroperoxy-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-methylthioethyl estra-4,9(11)-diene 3,17-dione [MeSH Supplementary Concept]
- 10-oxirane-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10-thiirane-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 10beta-chloro-17beta-hydroxyestra-1,4-dien-3-one [MeSH Supplementary Concept]
- 11-(4-(N-methyl-N-cyclohexylmethylamino)phenyl)-17-(1-propinyl)-17-hydroxyl-4,9-estradiene-3-one [MeSH Supplementary Concept]
- 12 beta-bromoacetoxy-4-estrene-3,17-dione [MeSH Supplementary Concept]
- 14,15-secoestra-1,3,5(10)-trien-15-yne-3,17-diol [MeSH Supplementary Concept]
- 17 beta-acetoxy-3-methoxy-9-oxo-9,11-secoestra-1,3,5(10)-trien-11-oic acid [MeSH Supplementary Concept]
- 17 beta-hydroxy-10-methylthioestra-1,4-dien-3-one [MeSH Supplementary Concept]
- 17 beta-hydroxy-7 alpha-methyl-5-estren-3-one [MeSH Supplementary Concept]
- 17 beta-hydroxy-7 alpha-methylestr-5-en-3-one acetate [MeSH Supplementary Concept]
- 17 beta-hydroxyestra-5(10),9(11)-dien-3-one [MeSH Supplementary Concept]
- 17 beta-phenylaminocarbonyloxy-estra-1,3,5(10)-triene-3-methyl ether [MeSH Supplementary Concept]
- 17-(N,N-diisopropylcarbamoyl)estra-1,3,5(10)-triene-3-sulfonic acid [MeSH Supplementary Concept]
- 17-(N,N-diisopropylcarboxamide)estra-1,3,5(10)-triene-3-carboxylic acid [MeSH Supplementary Concept]
- 17-(N-t-butylcarboxamide)estra-1,3,5(10)-triene-3-carboxylic acid [MeSH Supplementary Concept]
- 17-alpha-(2-butynyl)-17 beta-hydroxyestra-4,9,11-trien-3-one [MeSH Supplementary Concept]
- 17-beta-O-(1-(2-carboxy-(2-hydroxy-4-methoxy-3-carboxamido)anilido)ethyl)1,3,5(10)-estratriene [MeSH Supplementary Concept]
- 17-hydroxy-10-mercaptoestr-4-en-3-one [MeSH Supplementary Concept]
- 17-hydroxy-11-(3'-sulfanylpropyl)oxy-estra-1,3,5(10)-trien-3-yl sulfamate [MeSH Supplementary Concept]
- 17-hydroxy-7-methyl-D-homoestra-4,16-dien-3-one [MeSH Supplementary Concept]
- 17-propynylestra-1,3,4(10)-triene-3,17-diol dicobalt hexacarbonyl [MeSH Supplementary Concept]
- 17-propynylestra-1,3,5-triene-3,17-diol dicyclopentadienyl dimolybdenum tetracarbonyl [MeSH Supplementary Concept]
- 17-thia-3-methoxy-8 alpha,14 beta-estra-1,3,5(10)-triene-17-dioxide [MeSH Supplementary Concept]
- 17beta-acetoxy-2-fluoro-3-methoxy-8alpha-estra-1,3,5(10)-triene [MeSH Supplementary Concept]
- 19-norspiroxenone [MeSH Supplementary Concept]
- 2,10,11,11a-tetrahydro-11a-methyl-1H-naphth(1,2-g)indol-7-ol [MeSH Supplementary Concept]
- 2,3-bisaza-A-nor-1,5(10)-estradien-17-ol [MeSH Supplementary Concept]
- 2-ethyl-3-O-sulfamoylestra-1,3,5(10)16-tetraene [MeSH Supplementary Concept]
- 2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene [MeSH Supplementary Concept]
- 2-methoxyestradiol-3,17-O,O-bis(sulfamate) [MeSH Supplementary Concept]
- 2-methoxyoestra-1,3,5(10),16-tetraene-3-carboxamide [MeSH Supplementary Concept]
- 2-methyl-A-nor-3-oxa-16-thia-D-homo-1,5(10),8,14-estratetraen-17-ol [MeSH Supplementary Concept]
- 2-phenyl-7-methyl-3-oxa-A-nor-14 beta-estra-1,5(10),6,8- tetraen-17 alpha-ol [MeSH Supplementary Concept]
- 3 beta,17 beta-diacetoxy-4-estrene [MeSH Supplementary Concept]
- 3,17-dihydroxy-5-estrene [MeSH Supplementary Concept]
- 3,17-dithia-A-nor-14 beta-estra-1,5(10),6,8-tetraene-17-dioxide [MeSH Supplementary Concept]
- 3,3,17,17-bis(ethylenedioxy)-5,10-oxidoestr-9(11)-ene [MeSH Supplementary Concept]
- 3-(n-dimethylaminoethyloxy)estra-1,3,5-triene [MeSH Supplementary Concept]
- 3-hydroxy-14,15-secoestra-1,3,5(10)-trien-15-yn-17-one [MeSH Supplementary Concept]
- 3-hydroxy-17-(4-nitrophenyldithio)-1,3,5(10)-estratriene [MeSH Supplementary Concept]
- 3-hydroxyestra-1,3,5(10),6-tetraen-17-one [MeSH Supplementary Concept]
- 3-methoxy-1' beta-methyl-1,11 alpha-methano-9 beta-estra-1,3,4(10)- trien-17 beta ol [MeSH Supplementary Concept]
- 3-methoxy-14,15-methylenestra-1,3,5(10),8-tetraen-17-ol [MeSH Supplementary Concept]
- 3-methoxy-5,6-secoestra-1,3,5(10),8,14-pentaene-17-one [MeSH Supplementary Concept]
- 3-methoxy-6-aza-12-thia-12-dioxo-B-nor-14 beta-estra-1,3,5(10),8-tetraen-17 alpha-ol [MeSH Supplementary Concept]
- 3-methoxy-7-oxaestra-1,3,5(10),8-tetraen-17(e)-ol [MeSH Supplementary Concept]
- 3-methoxyestra-1,3,5(10)-triene [MeSH Supplementary Concept]
- 4,6-estradiene-3,17-dione [MeSH Supplementary Concept]
- 4-(17-methoxy-17-(methoxymethyl)-estra-4,9-dien-11-yl)benzaldehyd-1-oxime [MeSH Supplementary Concept]
- 4-(17beta-methoxy-17alpha-(methoymethyl)-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-1-(E)-(O-(ethylamino)carbonyl)oxime [MeSH Supplementary Concept]
- 4-(3-hydroxyestra-1,3,5(10)-tetraen-16-yl)-2-methylene-4-butanolide [MeSH Supplementary Concept]
- 4-estren-3,17-diol [MeSH Supplementary Concept]
- 5,10-secoestr-5-yne-3,10,17-trione [MeSH Supplementary Concept]
- 6,6'-bi(7-allyl-3-oxo-4-estren-17-yl acetate) [MeSH Supplementary Concept]
- 6,6-spiroethylene-19-norspiroxene [MeSH Supplementary Concept]
- 6,7-benzo-3-methoxyestra-1,3,5(10),8,14-pentaen-17-one [MeSH Supplementary Concept]
- 7-alpha-methyl-19-nortestosterone 17-(1-adamantoate) [MeSH Supplementary Concept]
- 7-methyl-10,17-diacetoxy-4-estren-3-one [MeSH Supplementary Concept]
- 8,14-seco-3,5(10),9,11-estratetraene-3-methoxy-17 beta- hydroxy-14-one [MeSH Supplementary Concept]
- A-nor-3,16-dithia-D-homo-1,5(10),8,14-estratetraen-17-ol [MeSH Supplementary Concept]
- A-nor-3,7-bisthiaestra-1,5(10),8,14-tetraen-17(e)-ol [MeSH Supplementary Concept]
- A-nor-3-thiaestra-1,5(10),6,8,14-pentaene-17(e)-ol [MeSH Supplementary Concept]
- A-nor-3-thiaestra-1,5(10),8,14-tetraen-17(e)-ol [MeSH Supplementary Concept]
- A-nor-3-thiaestra-1,5(10)-dien-17 beta-ol [MeSH Supplementary Concept]
- EM 219 [MeSH Supplementary Concept]
- N-chloro-3-methoxy-16-aza-1,3,5(10)-estratrien-17-one [MeSH Supplementary Concept]
- N-chloro-3-methoxy-17-aza-homo-1,3,5(10)-estratrien-17-one [MeSH Supplementary Concept]
- N-chloro-3-methoxy-17-azahomo-1,3,5(10)-estratrien-16-one [MeSH Supplementary Concept]
- R 2956 [MeSH Supplementary Concept]
- RTI 3021-012 [MeSH Supplementary Concept]
- RTI 3021-022 [MeSH Supplementary Concept]
- SC 19773 [MeSH Supplementary Concept]
- U 26384 [MeSH Supplementary Concept]
- U 73343 [MeSH Supplementary Concept]
- aglepristone [MeSH Supplementary Concept]
- asoprisnil [MeSH Supplementary Concept]
- benz(3,4)-6-oxaestra-1,3,5(10),8-tetraen-17-ol [MeSH Supplementary Concept]
- bolandiol dipropionate [MeSH Supplementary Concept]
- butolame [MeSH Supplementary Concept]
- doisynolic acid [MeSH Supplementary Concept]
- estr-4-ene-3,11,17-trione [MeSH Supplementary Concept]
- estra-1,3,5(10)-trien-17-one-3-sulfonyl chloride [MeSH Supplementary Concept]
- estradienolone [MeSH Supplementary Concept]
- fenestradiene [MeSH Supplementary Concept]
- hexolame [MeSH Supplementary Concept]
- lilopristone [MeSH Supplementary Concept]
- lonaprisan [MeSH Supplementary Concept]
- methylestrenolone [MeSH Supplementary Concept]
- org 20781 [MeSH Supplementary Concept]
- org 31710 [MeSH Supplementary Concept]
- org 31806 [MeSH Supplementary Concept]
- org 33628 [MeSH Supplementary Concept]
- org 7797 [MeSH Supplementary Concept]
- oxolven [MeSH Supplementary Concept]
- pentolame [MeSH Supplementary Concept]
- prolame [MeSH Supplementary Concept]
- puboestrene [MeSH Supplementary Concept]
- pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate [MeSH Supplementary Concept]
- silabolin [MeSH Supplementary Concept]
- spiro-17 beta-oxiranylestra-1,3,5(10),6,8-pentaene-3-ol [MeSH Supplementary Concept]
- trendione [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients